Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
MRNA-2752 by Moderna for Transitional Cell Cancer (Urothelial Cell Cancer): Likelihood of Approval
MRNA-2752 is under clinical development by Moderna and currently in Phase I for Transitional Cell Cancer (Urothelial Cell Cancer). According...
Data Insights
MRNA-2752 by Moderna for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
MRNA-2752 is under clinical development by Moderna and currently in Phase I for Head And Neck Squamous Cell Carcinoma (HNSC)....